These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30606013)

  • 1. Site-Specific Chemical Conjugation of Antibodies by Using Affinity Peptide for the Development of Therapeutic Antibody Format.
    Kishimoto S; Nakashimada Y; Yokota R; Hatanaka T; Adachi M; Ito Y
    Bioconjug Chem; 2019 Mar; 30(3):698-702. PubMed ID: 30606013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel site-specific chemical conjugation of IgG antibodies by affinity peptide for immunoassays.
    Mori S; Abe A; Ishikawa N; Rafique A; Ito Y
    J Biochem; 2021 Feb; 169(1):35-42. PubMed ID: 32706869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoconjugation of an Fc-Specific Peptide Enables Efficient DAR 2 Antibody-Drug Conjugate Formation.
    Lee T; Kim JH; Kwon SJ; Park SH; Kim J; Kang HJ; Chung SJ
    Org Lett; 2020 Nov; 22(21):8419-8423. PubMed ID: 33074682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation.
    Matsuda Y; Malinao MC; Robles V; Song J; Yamada K; Mendelsohn BA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121981. PubMed ID: 32036254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, Optimization, and Structural Characterization of an Efficient Peptide-Based Photoaffinity Cross-Linking Reaction for Generation of Homogeneous Conjugates from Wild-Type Antibodies.
    Vance N; Zacharias N; Ultsch M; Li G; Fourie A; Liu P; LaFrance-Vanasse J; Ernst JA; Sandoval W; Kozak KR; Phillips G; Wang W; Sadowsky J
    Bioconjug Chem; 2019 Jan; 30(1):148-160. PubMed ID: 30566343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a High-Affinity Antibody-Binding Peptide for Site-Specific Modification.
    Muguruma K; Osawa R; Fukuda A; Ishikawa N; Fujita K; Taguchi A; Takayama K; Taniguchi A; Ito Y; Hayashi Y
    ChemMedChem; 2021 Jun; 16(11):1813-1820. PubMed ID: 33594831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer-Directed Conjugation of DNA to Therapeutic Antibodies.
    Skovsgaard MB; Mortensen MR; Palmfeldt J; Gothelf KV
    Bioconjug Chem; 2019 Aug; 30(8):2127-2135. PubMed ID: 31247138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-Directed Photo-Cross-Linking for Site-Specific Conjugation of IgG.
    Park J; Lee Y; Ko BJ; Yoo TH
    Bioconjug Chem; 2018 Oct; 29(10):3240-3244. PubMed ID: 30179444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current strategies in antibody engineering: Fc engineering and pH-dependent antigen binding, bispecific antibodies and antibody drug conjugates.
    Vincent KJ; Zurini M
    Biotechnol J; 2012 Dec; 7(12):1444-50. PubMed ID: 23125076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
    Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
    J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-Selective Antibody-Drug Conjugation by a Proximity-Driven S to N Acyl Transfer Reaction on a Therapeutic Antibody.
    Lee T; Kim JH; Kwon SJ; Seo JW; Park SH; Kim J; Jin J; Hong JH; Kang HJ; Sharma C; Choi JH; Chung SJ
    J Med Chem; 2022 Apr; 65(7):5751-5759. PubMed ID: 35319890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximity-Induced Site-Specific Antibody Conjugation.
    Yu C; Tang J; Loredo A; Chen Y; Jung SY; Jain A; Gordon A; Xiao H
    Bioconjug Chem; 2018 Nov; 29(11):3522-3526. PubMed ID: 30372039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrapeptide-based mimotope affinity monolith for the enrichment and analysis of anti-HER2 antibody and antibody-drug conjugate.
    Zhu C; Han H; Chen Z; Shen Y; Zhang Q; Bao C; Qu JH; Wang Q; Jiang Z
    Anal Chim Acta; 2023 Mar; 1246():340892. PubMed ID: 36764776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent Chemical Ligation Strategy for Mono- and Polyclonal Immunoglobulins at Their Nucleotide Binding Sites.
    Lac D; Feng C; Bhardwaj G; Le H; Tran J; Xing L; Fung G; Liu R; Cheng H; Lam KS
    Bioconjug Chem; 2016 Jan; 27(1):159-69. PubMed ID: 26630124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal α-amino group modification of antibodies using a site-selective click chemistry method.
    Li DZ; Han BN; Wei R; Yao GY; Chen Z; Liu J; Poon TCW; Su W; Zhu Z; Dimitrov DS; Zhao Q
    MAbs; 2018 Jul; 10(5):712-719. PubMed ID: 29652547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monomeric IgG1 Fc molecules displaying unique Fc receptor interactions that are exploitable to treat inflammation-mediated diseases.
    Ying T; Feng Y; Wang Y; Chen W; Dimitrov DS
    MAbs; 2014; 6(5):1201-10. PubMed ID: 25517305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody-Drug Conjugate Synthesis.
    Matsuda Y; Shikida N; Hatada N; Yamada K; Seki T; Nakahara Y; Endo Y; Shimbo K; Takahashi K; Nakayama A; Mendelsohn BA; Fujii T; Okuzumi T; Hirasawa S
    Org Lett; 2024 Jul; 26(27):5597-5601. PubMed ID: 38639400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody-Drug Conjugate Production.
    Fujii T; Matsuda Y; Seki T; Shikida N; Iwai Y; Ooba Y; Takahashi K; Isokawa M; Kawaguchi S; Hatada N; Watanabe T; Takasugi R; Nakayama A; Shimbo K; Mendelsohn BA; Okuzumi T; Yamada K
    Bioconjug Chem; 2023 Mar; 34(4):728-38. PubMed ID: 36894324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific Conjugation of the Hinge Region for Homogeneous Preparation of Antibody Fragment-Drug Conjugate: A Case Study for Doxorubicin-PEG-anti-CD20 Fab' Synthesis.
    Zhou Z; Zhang J; Zhang Y; Ma G; Su Z
    Bioconjug Chem; 2016 Jan; 27(1):238-46. PubMed ID: 26700095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled antibody immobilization onto immunoanalytical platforms by synthetic peptide.
    Jung Y; Kang HJ; Lee JM; Jung SO; Yun WS; Chung SJ; Chung BH
    Anal Biochem; 2008 Mar; 374(1):99-105. PubMed ID: 18023402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.